Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Prostate Cancer and Prostatic Diseases|June 15, 2004
Polymorphisms of GSTP1 and related genes and prostate cancer riskT M Beer, A J Evans, K M Hough, et al.
British Journal of Cancer|August 2, 2012
Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials ConsortiumT M Beer, D C Smith, A Hussain, et al.
The Prostate|December 18, 2001
Association of codon 72 polymorphism of p53 with lower prostate cancer riskW D Henner, A J Evans, K M Hough, et al.
BJU International|March 11, 2004
Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohortM el-Geneidy, M Garzotto, I Panagiotou, et al.
Head & Neck|August 15, 2000
Genetic polymorphisms in head and neck cancer riskJ E McWilliams, A J Evans, T M Beer, et al.
International Journal of Obesity (2005)|August 19, 2016
Perpetuating effects of androgen deficiency on insulin resistanceJ L Cameron, R Jain, M Rais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2013
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studyS F Slovin, C S Higano, O Hamid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2018
Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancerA J Armstrong, P Lin, C S Higano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAILJ N Graff, G Baciarello, A J Armstrong, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAILA H Bryce, J J Alumkal, A Armstrong, et al.
Pageof 3